Taiwanese Team Highlights Precision Indoxyl Sulfate Testing for Early CKD Management in Japan

TOKYO, Sept. 24, 2026 /PRNewswire/ -- Chronic kidney disease (CKD) is often called a "silent disease" because its early stages may cause few noticeable symptoms. Taiwan has one of the world's highest burdens of end-stage renal disease requiring hemodialysis. Approximately 1.5 million Taiwanese adults are estimated to have Stage 3–5 CKD, yet fewer than 10% of patients are aware of their condition. These challenges highlight the need for reliable tools that support earlier risk identification and precision disease management. Leadgene Biomedical, a Taiwanese developer of antibodies and diag…READ FULL ARTICLE